Combination Therapy with Radiation and PARP Inhibition Enhances Responsiveness to Anti-PD-1 Therapy in Colorectal Tumor Models
Steven N. Seyedin(University of California, San Francisco), Joseph M. Caster(University of Iowa Hospitals and Clinics), Douglas R. Spitz(University of Iowa), Cameron M. Callaghan(Mayo Clinic in Arizona), Vivan Pham(University of Iowa), Amanda L. Kalen(University of Iowa), Kranti A. Mapuskar(University of Iowa Hospitals and Clinics), Michael S. Petronek(University of Iowa), M.M. Hasibuzzaman(University of Iowa), Bryan G. Allen(University of Iowa Hospitals and Clinics), Sarah L. Mott(University of Iowa)
International Journal of Radiation Oncology*Biology*Physics
February 6, 2020
Cited by 49
Related Papers
Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma
|Journal of Surgical Oncology|2014|274
Indications for and outcome of total abdominal hysterectomy for benign disease: a prospective cohort study
|BJOG An International Journal of Obstetrics & Gynaecology|1995|215
HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells
|Clinical Cancer Research|2012|203
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
|The Journal of Urology|2019|190